The Ross procedure is the only valve replacement strategy that can restore life expectancy in selected young and middle-aged adults, underscoring its significance in treatment options.
Does the Ross procedure improve long-term survival and reduce valve-related complications compared to prosthetic valves in young and middle-aged adults requiring aortic valve replacement?
The Ross procedure is uniquely capable of restoring normal life expectancy in carefully selected young and middle-aged adults requiring aortic valve replacement, offering superior hemodynamics and avoiding the need for lifelong anticoagulation.
Absolute Event Rate: 0% vs 0%
Renewed interest in the Ross procedure, driven by compelling evidence of superior long‐term outcomes, has led to increased international use. This review outlines a comprehensive framework for understanding the Ross procedure within the broader context of aortic valve replacement. Topics include procedural overview, patient selection and contraindications, diagnostic imaging, technical modifications to promote durability, clinical outcomes, postoperative management, and future directions. The Ross procedure remains the only valve replacement strategy capable of restoring life expectancy in selected young and middle‐aged adults, making it an imperative option for multidisciplinary consideration.
Bloom et al. (Tue,) reported a other. The Ross procedure is the only valve replacement strategy that can restore life expectancy in selected young and middle-aged adults, underscoring its significance in treatment options.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: